Antifibrotic biomaterials

Abstract

Fibrosis is a major cause of organ dysfunction and mortality, yet current therapies rarely reverse established disease. Biomaterials offer new opportunities to locally modulate tissue-specific repair environments and guide healing away from scar formation and toward regeneration.